Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study
Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study
Objective: to test the hypothesis that abnormalities in the hypothalamic-pituitary-adrenal (HPA) stress-response system would act as an effect moderator between HPA function and the onset of chronic widespread pain (CWP).
Methods: we conducted a population-based prospective cohort study. Current pain and psychosocial status were ascertained in 11,000 subjects. Of the 768 eligible subjects free of CWP but at future risk based on their psychosocial profile, 463 were randomly selected, and 267 (57.7%) consented to assessment of their HPA axis function. Diurnal function was measured by assessing levels of salivary cortisol in the morning (9:00 AM) and evening (10:00 PM). Serum cortisol levels were measured after an overnight low-dose (0.25 mg) dexamethasone suppression test and a potentially stressful clinical examination. All subjects were followed up 15 months later to identify cases of new-onset CWP.
Results: a total of 241 subjects (94.9%) completed the followup study, and 28 (11.6%) reported the new onset of CWP. High levels of cortisol post-dexamethasone (odds ratio [OR] 3.53, 95% confidence interval [95% CI] 1.17-10.65), low levels in morning saliva (OR 1.43, 95% CI 0.52-3.94), and high levels in evening saliva (OR 2.32, 95% CI 0.64-8.42) were all associated with CWP. These 3 factors were found to be independent and additive predictors of CWP (OR for all 3 factors 8.5, 95% CI 1.5-47.9) in analyses controlling for age, sex, depression, sleep disturbance, recent traumatic life events, and pain status. One or more of these 3 HPA factors identified 26 (92.9%) cases of new-onset CWP.
Conclusion: among a group of psychologically at-risk subjects, dysfunction of the HPA axis helps to distinguish those who will and will not develop new-onset CWP.
360-371
McBeth, J.
98012716-66ba-480b-9e43-ac53b51dce61
Silman, A.J.
1ab1fc13-51f5-44c8-92f1-0bb32a5c5754
Gupta, A.
2ef49e58-f9e2-4142-bf0a-aaa1ac8bfdc5
Chiu, Y.H.
5e07bd25-bfae-479b-afc5-a1ed9db36359
Ray, D.
5ed234c6-4431-4293-acf2-25de1f7e0981
Morriss, R.
30d5dc2c-4140-4181-9bbd-a70c6c9dcb17
Dickens, C.
a41afee4-9852-4e66-a96d-938151d8fd3a
King, Y.
e3088b13-1a9a-4804-8c9b-17521298b04c
Macfarlane, G.J.
e17bbdb7-9d82-42ac-8a0a-09bf10885e3c
2 January 2007
McBeth, J.
98012716-66ba-480b-9e43-ac53b51dce61
Silman, A.J.
1ab1fc13-51f5-44c8-92f1-0bb32a5c5754
Gupta, A.
2ef49e58-f9e2-4142-bf0a-aaa1ac8bfdc5
Chiu, Y.H.
5e07bd25-bfae-479b-afc5-a1ed9db36359
Ray, D.
5ed234c6-4431-4293-acf2-25de1f7e0981
Morriss, R.
30d5dc2c-4140-4181-9bbd-a70c6c9dcb17
Dickens, C.
a41afee4-9852-4e66-a96d-938151d8fd3a
King, Y.
e3088b13-1a9a-4804-8c9b-17521298b04c
Macfarlane, G.J.
e17bbdb7-9d82-42ac-8a0a-09bf10885e3c
McBeth, J., Silman, A.J., Gupta, A., Chiu, Y.H., Ray, D., Morriss, R., Dickens, C., King, Y. and Macfarlane, G.J.
(2007)
Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study.
Arthritis and Rheumatism, 56 (1), .
(doi:10.1002/art.22336).
Abstract
Objective: to test the hypothesis that abnormalities in the hypothalamic-pituitary-adrenal (HPA) stress-response system would act as an effect moderator between HPA function and the onset of chronic widespread pain (CWP).
Methods: we conducted a population-based prospective cohort study. Current pain and psychosocial status were ascertained in 11,000 subjects. Of the 768 eligible subjects free of CWP but at future risk based on their psychosocial profile, 463 were randomly selected, and 267 (57.7%) consented to assessment of their HPA axis function. Diurnal function was measured by assessing levels of salivary cortisol in the morning (9:00 AM) and evening (10:00 PM). Serum cortisol levels were measured after an overnight low-dose (0.25 mg) dexamethasone suppression test and a potentially stressful clinical examination. All subjects were followed up 15 months later to identify cases of new-onset CWP.
Results: a total of 241 subjects (94.9%) completed the followup study, and 28 (11.6%) reported the new onset of CWP. High levels of cortisol post-dexamethasone (odds ratio [OR] 3.53, 95% confidence interval [95% CI] 1.17-10.65), low levels in morning saliva (OR 1.43, 95% CI 0.52-3.94), and high levels in evening saliva (OR 2.32, 95% CI 0.64-8.42) were all associated with CWP. These 3 factors were found to be independent and additive predictors of CWP (OR for all 3 factors 8.5, 95% CI 1.5-47.9) in analyses controlling for age, sex, depression, sleep disturbance, recent traumatic life events, and pain status. One or more of these 3 HPA factors identified 26 (92.9%) cases of new-onset CWP.
Conclusion: among a group of psychologically at-risk subjects, dysfunction of the HPA axis helps to distinguish those who will and will not develop new-onset CWP.
This record has no associated files available for download.
More information
Accepted/In Press date: 13 October 2006
Published date: 2 January 2007
Identifiers
Local EPrints ID: 492847
URI: http://eprints.soton.ac.uk/id/eprint/492847
ISSN: 0004-3591
PURE UUID: 40270f11-e5e6-4191-a303-08a3f9a8466b
Catalogue record
Date deposited: 15 Aug 2024 17:03
Last modified: 16 Aug 2024 02:11
Export record
Altmetrics
Contributors
Author:
J. McBeth
Author:
A.J. Silman
Author:
A. Gupta
Author:
Y.H. Chiu
Author:
D. Ray
Author:
R. Morriss
Author:
C. Dickens
Author:
Y. King
Author:
G.J. Macfarlane
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics